Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate
- 31 May 2009
- journal article
- Published by Elsevier in Contraception
- Vol. 79 (5), 345-349
- https://doi.org/10.1016/j.contraception.2008.11.009
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective studyFertility and Sterility, 2008
- Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetateFertility and Sterility, 2006
- Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girlsJournal of Adolescent Health, 2004
- Injectable Hormone Contraception and Bone Density: Results from a Prospective StudyEpidemiology, 2002
- Steroid hormone contraception and bone mineral density: a cross-sectional study in an international populationPublished by Wolters Kluwer Health ,2000
- Forearm bone density in users of Depo-Provera as a contraceptive methodFertility and Sterility, 1999
- Bone mineral density in women using depot medroxyprogesterone acetate for contraceptionObstetrics & Gynecology, 1999
- A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptivesThe Journal of Pediatrics, 1996
- A randomized double blind placebo controlled trial of the effects on bone metabolism of the combination of nafarelin acetate and norethisteroneClinical Endocrinology, 1992
- Bone density in women receiving depot medroxyprogesterone acetate for contraception.BMJ, 1991